RE: Minimisation problem...
Dear Gavin,
It would seem the first place to start is with your structural model. A 3rd
order polynomial with IIV on the parameters should give a perfect fit to every
subject subject with <= 3 sampling points. How about a more mechanistic
approach? It sounds like you are modelling the change in some kind of
biomarker that returns to baseline, so maybe a turnover model is appropriate.
Have a look at:
Mager DE, Wyska E, Jusko WJ. Diversity of mechanism-based pharmacodynamic
models. Drug Metab Dispos. 2003 May;31(5):510-8
A covariate on production or inhibition rate which varies between treatment and
control would tell you if there is a difference between groups.
BW,
Joe
Joseph F Standing
MRC Fellow, UCL Institute of Child Health
Antimicrobial Pharmacist, Great Ormond Street Hospital
Tel: +44(0)207 905 2370
Mobile: +44(0)7970 572435
Quoted reply history
________________________________________
From: [email protected] [[email protected]] On Behalf Of
Gavin Jarvis [[email protected]]
Sent: 09 January 2013 10:19
To: [email protected]
Subject: [NMusers] Minimisation problem...
Dear NMusers
I am trying to analyse data from a study in which samples were taken from each
subject at 4 different time points (t=0,5,10,14). The problem with the data is
that there are many missing data points and there is considerable variation
between the subjects.
The subjects are in either a control or a test group, and I want to determine
whether there is any difference in the data values between these groups.
Overall, it looks like the data values increase with time, but there is a
suggestion that in the test group the increase is not sustained but returns to
baseline levels by t=14, whereas the control group is either levelled off or
possibly still rising.
I have used a polynomial model to fit the data up to the 3rd power (which I
think is probably too much) and included additive parameters to modify each of
the coefficients from the polynomial model.
The problem I have is as follows:
When I use the FOCE method the ETA terms collapse towards zero. The quality of
the fit looks poor when judged by a plot of DV against individual predicted
values.
When I use the BAYES method, I get credible ETA values and a much better fit
(i.e., DV vs ipred clusters sensibly around a line of unity).
However, I cannot use the OBJV value from the BAYES method to carry out
hypothesis testing. The final reported parameter estimates following the BAYES
method are sensitive to initial starting values and the number of iterations
performed. If I use the parameter values obtained with the BAYES method I can
determine an accurate OBJV for those parameter values using FOCE with just 1
evaluation. However, if I perform a minimisation with FOCE starting with those
values, the ETA values collapse and the DV vs ipred plot looks awful again.
I hope this makes some sense to someone out there ā Iām a bit of a novice at
NONMEM. I realise the data is far from ideal, but it would be great to get some
statistical information about the difference between the two groups. If anyone
had any suggestions I would be grateful. The biological interpretation of the
experiment will change significantly depending on which way this goes!
Thanks
Gavin
__________________________________________________
Dr Gavin E Jarvis MA PhD VetMB MRCVS
University Lecturer
Department of Physiology, Development & Neuroscience
Physiological Laboratory
Downing Street
Cambridge
CB2 3EG
Tel: +44 (0) 1223 333745
Email: [email protected]<mailto:[email protected]>
********************************************************************************************************************
This message may contain confidential information. If you are not the intended
recipient please inform the
sender that you have received the message in error before deleting it.
Please do not disclose, copy or distribute information in this e-mail or take
any action in reliance on its contents:
to do so is strictly prohibited and may be unlawful.
Thank you for your co-operation.
NHSmail is the secure email and directory service available for all NHS staff
in England and Scotland
NHSmail is approved for exchanging patient data and other sensitive information
with NHSmail and GSi recipients
NHSmail provides an email address for your career in the NHS and can be
accessed anywhere
********************************************************************************************************************